| Literature DB >> 29023586 |
Raquel García-García1, Álvaro Javier Cruz-Gómez2, Alba Mangas-Losada3, Amparo Urios1,3, Cristina Forn2, Desamparados Escudero-García4, Elena Kosenko5, Juan Fermín Ordoño6,7, Joan Tosca4, Remedios Giner-Durán8, Miguel Angel Serra4, César Avila2, Vicente Belloch9, Vicente Felipo1, Carmina Montoliu3,10.
Abstract
BACKGROUND AND AIMS: Minimal hepatic encephalopathy (MHE) is associated with cognitive alterations and changes in connectivity. We assessed the relationship of the abnormalities of resting-state functional connectivity (rs-FC) and gray matter (GM) volume with different cognitive alterations and biochemical parameters associated to MHE.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29023586 PMCID: PMC5638549 DOI: 10.1371/journal.pone.0186463
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Composition of the different groups and etiology of liver disease.
| Controls | nMHE patients | MHE patients | |
|---|---|---|---|
| 24 | 26 | 13 | |
| 16/8 | 20/6 | 12/1 | |
| 61 ± 6 | 63 ± 9 | 64 ± 11 | |
| ----- | 11 | 6 | |
| ----- | 0/11/1 | 0/3/1 | |
| 3 | 3 | ||
| ----- | 23/3/0 | 8/5/0 | |
| ----- | 9 ± 2 | 12 ± 5 |
*Values are expressed as mean ± SD. In brackets: age range. MHE, minimal hepatic encephalopathy; HBV, hepatitis B virus; HCV, hepatitis C virus. MELD, model end stage liver disease. The Child Pugh Score is derived from a score of 1–3 given for severity of ascites, hepatic encephalopathy, INR, albumin and bilirubin. The higher the score is, the more severe the liver disease.
Performance in neuropsychological tests and results of biochemical determinations.
| Controls | nMHE patients | MHE patients | MHE patients | Global | |
|---|---|---|---|---|---|
| 0.9 ± 0.2 | -0.9 ± 0.3 | -7.3 ± 1 | |||
| 44 ± 2 | 28 ± 2 | 19 ± 2 | |||
| 29 ± 2 | 39 ± 3 | 67 ± 11 | |||
| 72 ± 5 | 109 ± 9 | 243 ± 46 | |||
| 59 ± 3 | 80 ± 3 | 125 ± 10 | |||
| 98 ± 3 | 124 ± 6 | 220 ± 16 | |||
| 1.9 ± 0.04 | 2.2 ± 0.05 | 3.3 ± 0.3 | |||
| 2.3 ± 0.07 | 2.8 ± 0.1 | 4.4 ± 0.5 | |||
| 426 ± 16 | 300 ± 16 | 238 ± 37 | |||
| 393 ± 92 | 276 ± 15 | 194 ± 28 | |||
| 156 ± 7 | 101 ± 7 | 57 ± 15 | |||
| 157 ± 7 | 108 ± 7 | 71 ± 11 | |||
| 117 ± 3 | 98 ± 3 | 75 ± 4 | |||
| 82 ± 3 | 74 ± 3 | 55 ± 3 | |||
| 46 ± 2 | 39 ± 2 | 28 ± 2 | |||
| 51 ± 1 | 38 ± 2 | 24 ± 3 | |||
| 9.3 ± 0.5 | 7.6 ± 0.3 | 7.0 ± 0.4 | |||
| 6.5 ± 0.6 | 4.8 ± 0.3 | 3.8 ± 0.5 | |||
| 16 ± 0.9 | 12 ± 0.4 | 11 ± 0.7 | ns | ||
| 9.9 ± 0.5 | 7.2 ± 0.5 | 5.9 ± 0.7 | |||
| 9 ± 1 | 27 ± 5 | 35 ± 7 | |||
| 4 ± 0.2 | 8 ±1 | 12 ± 1 | |||
| 1.5 ± 0.1 | 2.4 ±0.2 | 4.2 ± 0.6 | |||
| 140 ± 17 | 227 ±17 | 305 ± 27 |
Values are expressed as mean ± SEM. nMHE and MHE, patients without and with Minimal Hepatic Encephalopathy, respectively; PHES, Psychometric Hepatic Encephalopathy Score; DST, Digit Symbol Test; NCT-A, NCT-B: Number Connection Test A and B; SD, Serial Dotting Test; LTT, Line Tracing Test; d2 test: TR, Total number of characters processed; TOT, Total correctly processed; CON, Concentration performance; TA, Total right answers.
a Stroop test: Congruent task: number of words read in 45 seconds; Neutral task: number of colours read in 45 seconds; Incongruent task: number of items completed in 45 seconds. Oral SDMT, Symbol digit modalities test (oral version).
b Right answers. Differences between groups were analyzed using one-way ANOVA followed by post-hoc Bonferroni. Significant differences compared to controls are indicated by asterisks
*p<0.05
**p<0.01
***p<0.001.
Areas showing significant gray matter (GM) volume differences between groups including gender as nuisance covariate.
| Contrast | Anatomical Localization | k | MNI | t value | ||
|---|---|---|---|---|---|---|
| x | y | z | ||||
| L Cerebellum (lobule III) | 574 | -8 | -34 | -16 | 6.36 | |
| R Cerebellum (lobule III) | 8 | -37 | -19 | 4.62 | ||
| L Cerebellum (lobule IV-V) | -13 | -37 | -19 | 4.37 | ||
| L Putamen | 6444 | -18 | 3 | -12 | 5.73 | |
| R Putamen | 24 | 9 | -5 | 5.05 | ||
| L Caudate | -14 | 15 | 5 | 5.24 | ||
| R Caudate | 15 | 14 | 9 | 4.93 | ||
| L Insula | -34 | 21 | 3 | 5.27 | ||
| L Parahippocampal Gyrus | -20 | -16 | -21 | 3.42 | ||
| R Parahippocampal Gyrus | 20 | 7 | -22 | 3.61 | ||
| L Hippocampus | -25 | -9 | -15 | 4.30 | ||
| R Hippocampus | 25 | -9 | -15 | 5.52 | ||
| L Amygdala | -21 | -6 | -15 | 3.69 | ||
| R Amygdala | 25 | 5 | -16 | 3.76 | ||
| L Rectus | -2 | 14 | -20 | 5.02 | ||
| R Rectus | 3 | 14 | -21 | 4.90 | ||
| L Superior Temporal Pole | -26 | 8 | -21 | 4.23 | ||
| R Superior Temporal Pole | 26 | 8 | -21 | 4.54 | ||
| L Olfactory Lobe | -8 | 7 | -14 | 4.14 | ||
| R Olfactory Lobe | 3 | 10 | -14 | 3.51 | ||
| R Inferior Frontal Gyrus (pars orbitalis) | 2 | 54 | -14 | 3.52 | ||
| L Inferior Frontal Gyrus (pars triangularis) | -38 | 22 | -2 | 4.36 | ||
| R Insula | 920 | 39 | 3 | 11 | 5.32 | |
| R Inferior Frontal Gyrus (pars triangularis) | 44 | 25 | 3 | 4.44 | ||
| R Rolandic Operculum | 45 | -4 | 12 | 3.38 | ||
| L Rolandic Operculum | 559 | -38 | -18 | 18 | 5.15 | |
| L Heschl Gyrus | -36 | -22 | 11 | 3.90 | ||
| L Middle Cingulate Cortex | 1246 | -3 | -39 | 39 | 4.70 | |
| R Middle Cingulate Cortex | 2 | -37 | 39 | 3.86 | ||
| L Posterior Cingulate Cortex | -2 | -50 | 30 | 3.42 | ||
| R Posterior Cingulate Cortex | 2 | -50 | 30 | 3.63 | ||
| L Precuneus | -2 | -63 | 47 | 4.39 | ||
| R Precuneus | 3 | -54 | 44 | 4.52 | ||
| L Paracentral Lobule | -5 | -33 | 51 | 3.53 | ||
| L Medial Orbitofrontal Cortex | 461 | -2 | 60 | -14 | 3.60 | |
| R Medial Orbitofrontal Cortex | 2 | 56 | -14 | 3.54 | ||
| L Cerebellum (lobule VI) | 433 | -35 | -44 | -33 | 4.38 | |
| L Cerebellum (Crus 1) | -35 | -55 | -29 | 4.14 | ||
| L Supplementary Motor Area | 460 | -2 | -5 | 50 | 3.54 | |
| R Supplementary Motor Area | 2 | -5 | 50 | 3.33 | ||
| L Cerebellum (lobule VII B) | 491 | -26 | -73 | -51 | 3.55 | |
| L Cerebellum (lobule VIII) | -18 | -69 | -54 | 4.14 | ||
| L Cerebellum (lobule IX) | -6 | -60 | -50 | 3.08 | ||
| R Cerebellum (lobule IX) | 323 | 5 | -53 | -54 | 3.83 | |
| R Cerebellum (lobule VIII) | 8 | -67 | -47 | 3.29 | ||
| Cerebellum (lobule VIII of Vermis) | -5 | -69 | -41 | 4.10 | ||
| L Anterior Cingulate Cortex | 561 | -3 | 33 | 20 | 4.01 | |
| R Anterior Cingulate Cortex | 2 | 32 | 20 | 3.55 | ||
| L Medial Frontal Gyrus | -2 | 22 | 41 | 3.42 | ||
| R Cerebellum (Crus I) | 668 | 11 | -81 | -27 | 5.72 | |
| R Cerebellum (Crus II) | 24 | -78 | -39 | 3.81 | ||
| R Cerebellum (lobule VI) | 14 | -78 | -22 | 3.92 | ||
| Cerebellum (lobule VII of Vermis) | 6 | -76 | -27 | 3.94 | ||
| Cerebellum (lobule VIII of Vermis) | 5 | -69 | -41 | 4.06 | ||
| R Insula | 653 | 39 | 3 | 11 | 4.79 | |
| R Rolandic Operculum | 44 | -2 | 14 | 3.54 | ||
| R Inferior Frontal Gyrus (pars opercularis) | 45 | 14 | 8 | 3.38 |
All results were assessed at p<0.05 FWE cluster-corrected for the multiple comparisons in a combination with a threshold of p<0.001 at the uncorrected voxel level. HC, healthy controls; nMHE and MHE, patients without and with minimal hepatic encephalopathy, respectively. MNI: Montreal Neurological Institute; L, left; R, right; k: extend threshold k voxels; t: value of height threshold t.
Fig 1Localization of gray matter atrophy between groups including gender as nuisance covariate.
All results were assessed at p<0.05 FWE cluster-corrected for the multiple comparisons in a combination with a threshold of p<0.001 at the uncorrected voxel level. HC, Healthy Controls; nMHE, patients without Minimal Hepatic Encephalopathy; MHE, patients with Minimal Hepatic Encephalopathy; GM, Gray Matter. Images are in neurological convention.
Correlations between GM volume and cognitive and biochemical variables.
| Brain Region | Predictor | r | p |
|---|---|---|---|
| PHES | 0.657 | <0.01 | |
| Serial Dotting Test | -0.457 | <0.01 | |
| Line tracing test | -0.608 | <0.01 | |
| Stroop (Incongruent task) | 0.426 | <0.05 | |
| Visuomotor coordination | -0.341 | <0.05 | |
| d2-TR | 0.393 | <0.05 | |
| d2-TOT | 0.424 | <0.05 | |
| cGMP | -0.396 | <0.05 | |
| IL-6 | -0.650 | <0.01 | |
| MELD | -0.441 | <0.01 | |
| Child-Pugh | -0.472 | <0.01 | |
| PHES | 0.755 | <0.01 | |
| Digit symbol test | 0.481 | <0.01 | |
| NCT-A | -0.347 | <0.05 | |
| NCT-B | -0.512 | <0.01 | |
| Serial Dotting Test | -0.682 | <0.01 | |
| Line tracing test | -0.679 | <0.01 | |
| Stroop(Incongruent task) | 0.499 | <0.01 | |
| d2-TR | 0.385 | <0.05 | |
| d2-TOT | 0.363 | <0.05 | |
| Oral SDMT | 0.517 | <0.01 | |
| Digit Span -Backward | 0.368 | <0.05 | |
| cGMP | -0.381 | <0.05 | |
| IL-6 | -0.408 | <0.05 | |
| MELD | -0.444 | <0.01 | |
| Child-Pugh | -0.387 | <0.05 |
The p and r values of the correlation analysis in all patients group are shown. Abbreviations: PHES, Psychometric Hepatic Encephalopathy Score; NCT-A, NCT-B: Number Connection Test A and B; d2 test: d2-TR, Total number of characters processed; d2-TOT, Total correctly processed; Oral SDMT, Symbol Digit Modalities test, oral version; MELD, model end stage liver disease.
Differences among groups in the resting-state functional connectivity (rs-FC) networks including gender as a nuisance variable.
| Anatomical Localization | k | MNI | t value | |||
|---|---|---|---|---|---|---|
| x | y | z | ||||
| L Precuneus | 39 | -3 | -57 | 33 | 3.65 | |
| R Precuneus | 3 | -57 | 33 | 3.64 | ||
| L Cingulate Gyrus | -3 | -48 | 24 | 3.95 | ||
| R Cingulate Gyrus | 1 | -49 | 30 | 3.94 | ||
| L Precuneus | 114 | -1 | -47 | 42 | 3.72 | |
| R Precuneus | 6 | -51 | 45 | 4.89 | ||
| L Cingulate Gyrus | -3 | -45 | 27 | 4.14 | ||
| R Cingulate Gyrus | 3 | -45 | 27 | 4.67 | ||
| L Precuneus | 23 | -1 | -48 | 42 | 3.66 | |
| R Precuneus | 3 | -48 | 42 | 3.44 | ||
| L Cingulate Gyrus | -3 | -39 | 42 | 3.51 | ||
| R Cingulate Gyrus | 3 | -39 | 42 | 3.96 | ||
| L Superior Parietal Lobule | 41 | -33 | -66 | 48 | 4.61 | |
| L Inferior Parietal Lobule | -30 | -57 | 42 | 3.92 | ||
| L Inferior Frontal Gyrus | 36 | 45 | 24 | 18 | 4.55 | |
| R Middle Occipital Gyrus | 47 | 30 | -66 | 33 | 5.46 | |
| R Superior Occipital Gyrus | 27 | -69 | 35 | 3.66 | ||
| R Angular Gyrus | 30 | -57 | 42 | 4.15 | ||
| R Supplementary Motor Area | 21 | 9 | 12 | 48 | 4.29 | |
| L Supplementary Motor Area | -2 | 18 | 45 | 3.38 | ||
| L Cingulate Gyrus | 21 | -6 | 12 | 36 | 4.09 | |
| R Cingulate Gyrus | 9 | 15 | 39 | 3.63 | ||
All results were assessed at p<0.05 FWE cluster-corrected for the multiple comparisons in a combination with a threshold of p<0.001 at the uncorrected voxel level. HC, healthy controls; nMHE and MHE, patients without and with minimal hepatic encephalopathy, respectively. MNI: Montreal Neurological Institute; L, left; R, right; k: extend threshold K voxels; t: value of height threshold t.
Fig 2Differences among groups in the resting-state functional connectivity (rs-FC) networks including gender as a nuisance variable.
All results were assessed at p<0.05 FWE cluster-corrected for the multiple comparisons in a combination with a threshold of p<0.001 at the uncorrected voxel level. HC, Healthy Controls; nMHE, patients without Minimal Hepatic Encephalopathy; MHE, patients with Minimal Hepatic Encephalopathy; DMN, Default Mode Network; LFPN, Left Fronto Parietal Network; DAN, Dorsal Attentional Network; SN, Salience Network; BGN, Basal Ganglia Network. Images are in neurological convention.
Correlations among resting-state functional connectivity (rs-FC) networks and cognitive and biochemical variables.
| Group | Dependent | Predictor | r | Anatomical Localization | |
|---|---|---|---|---|---|
| All patients | DMN | PHES | 0.62 | <0.01 | Bilateral Precuneus and Cingulate Gyrus |
| All patients | DMN | Digit Symbol Test | 0.38 | <0.05 | Bilateral Precuneus and Cingulate Gyrus |
| All patients | DMN | Serial Dotting test | -0.57 | <0.01 | Bilateral Precuneus and Cingulate Gyrus |
| All patients | DMN | Line tracing test | -0.54 | <0.01 | Bilateral Precuneus and Cingulate Gyrus |
| All patients | DMN | NCT-A | -0.35 | <0.05 | Bilateral Precuneus and Cingulate Gyrus |
| All patients | DMN | NCT-B | -0.43 | <0.05 | Bilateral Precuneus and Cingulate Gyrus |
| All patients | DMN | Bimanual coordination | -0.60 | <0.01 | Bilateral Precuneus and Cingulate Gyrus |
| All patients | DMN | Visuomotor coordination | -0.47 | <0.01 | Bilateral Precuneus and Cingulate Gyrus |
| nMHE | DMN | Oral SDMT | 0.45 | <0.05 | Bilateral Precuneus and Cingulate Gyrus |
| All patients | SN | PHES | 0.57 | <0.01 | Bilateral Supplementary Motor Area |
| All patients | SN | Serial Dotting test | -0.46 | <0.01 | Bilateral Supplementary Motor Area |
| All patients | SN | Line tracing test | -0.39 | <0.05 | Bilateral Supplementary Motor Area |
| All patients | SN | IL-6 | -0.38 | <0.05 | Bilateral Supplementary Motor Area |
| MHE | DAN | IL-18 | -0.78 | <0.05 | R Precuneus, R Parietal Lobe, R Occipital Middle and Superior Gyrus |
| All patients | BGN | PHES | 0.48 | <0.01 | Bilateral Cingulate Gyrus |
| All patients | BGN | Serial Dotting test | -0.46 | <0.01 | Bilateral Cingulate Gyrus |
| All patients | BGN | Stroop test (Incongruent task) | 0.51 | <0.01 | Bilateral Cingulate Gyrus |
| All patients | BGN | Child-Pugh | -0.44 | <0.05 | Bilateral anterior cingulate cortex |
The p and r values of the correlation analysis are shown. Abbreviations: BGN, Basal Ganglia Network; DAN, Dorsal Attentional Network; DMN, default mode network; L, Left; LFPN, left frontoparietal network; nMHE and MHE, patients without and with minimal hepatic encephalopathy, respectively; MELD, model end stage liver disease; NCT-A, NCT-B: Number Connection Test A and B; Oral SDMT, Symbol Digit Modalities test, oral version; PHES, Psychometric Hepatic Encephalopathy Score; R, right; SN, Salience network.